Lincoln Pharmaceuticals consolidated net profit rises 29.75% in the December 2023 quarter

Sales rise 9.48% to Rs 146.45 crore

Net profit of Lincoln Pharmaceuticals rose 29.75% to Rs 28.04 crore in the quarter ended December 2023 as against Rs 21.61 crore during the previous quarter ended December 2022. Sales rose 9.48% to Rs 146.45 crore in the quarter ended December 2023 as against Rs 133.77 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales146.45133.77 9 OPM %20.2520.00 -PBDT40.5232.78 24 PBT37.7130.51 24 NP28.0421.61 30

Powered by Capital Market - Live News